Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 72

1.

Phosphodiesterase 4 inhibition reduces innate immunity and improves isoniazid clearance of Mycobacterium tuberculosis in the lungs of infected mice.

Koo MS, Manca C, Yang G, O'Brien P, Sung N, Tsenova L, Subbian S, Fallows D, Muller G, Ehrt S, Kaplan G.

PLoS One. 2011 Feb 25;6(2):e17091. doi: 10.1371/journal.pone.0017091.

2.

Excess lung function decline in gold miners following pulmonary tuberculosis.

Ross J, Ehrlich RI, Hnizdo E, White N, Churchyard GJ.

Thorax. 2010 Nov;65(11):1010-5. doi: 10.1136/thx.2009.129999. Epub 2010 Sep 25.

PMID:
20871124
3.

Mycobacterium tuberculosis strains with the Beijing genotype demonstrate variability in virulence associated with transmission.

Aguilar D, Hanekom M, Mata D, Gey van Pittius NC, van Helden PD, Warren RM, Hernandez-Pando R.

Tuberculosis (Edinb). 2010 Sep;90(5):319-25. doi: 10.1016/j.tube.2010.08.004. Epub 2010 Sep 15.

PMID:
20832364
4.

How tumour necrosis factor blockers interfere with tuberculosis immunity.

Harris J, Keane J.

Clin Exp Immunol. 2010 Jul 1;161(1):1-9. doi: 10.1111/j.1365-2249.2010.04146.x. Epub 2010 May 18. Review.

5.

Mycobacterium tuberculosis upregulates microglial matrix metalloproteinase-1 and -3 expression and secretion via NF-kappaB- and Activator Protein-1-dependent monocyte networks.

Green JA, Elkington PT, Pennington CJ, Roncaroli F, Dholakia S, Moores RC, Bullen A, Porter JC, Agranoff D, Edwards DR, Friedland JS.

J Immunol. 2010 Jun 1;184(11):6492-503. doi: 10.4049/jimmunol.0903811. Epub 2010 May 5.

6.

MMP-1(-1607G) polymorphism as a risk factor for fibrosis after pulmonary tuberculosis in Taiwan.

Wang CH, Lin HC, Lin SM, Huang CD, Liu CY, Huang KH, Hsieh LL, Chung KF, Kuo HP.

Int J Tuberc Lung Dis. 2010 May;14(5):627-34.

PMID:
20392358
7.

Differential polarization of alveolar macrophages and bone marrow-derived monocytes following chemically and pathogen-induced chronic lung inflammation.

Redente EF, Higgins DM, Dwyer-Nield LD, Orme IM, Gonzalez-Juarrero M, Malkinson AM.

J Leukoc Biol. 2010 Jul;88(1):159-68. doi: 10.1189/jlb.0609378. Epub 2010 Apr 1.

8.

Advances in immunotherapy for tuberculosis treatment.

Churchyard GJ, Kaplan G, Fallows D, Wallis RS, Onyebujoh P, Rook GA.

Clin Chest Med. 2009 Dec;30(4):769-82, ix. doi: 10.1016/j.ccm.2009.08.009. Review.

PMID:
19925966
9.

STAT3, p38 MAPK, and NF-kappaB drive unopposed monocyte-dependent fibroblast MMP-1 secretion in tuberculosis.

O'Kane CM, Elkington PT, Jones MD, Caviedes L, Tovar M, Gilman RH, Stamp G, Friedland JS.

Am J Respir Cell Mol Biol. 2010 Oct;43(4):465-74. doi: 10.1165/rcmb.2009-0211OC. Epub 2009 Nov 13.

10.

The Yin-Yang of TNFalpha in the guinea pig model of tuberculosis.

Ly LH, McMurray DN.

Indian J Exp Biol. 2009 Jun;47(6):432-9. Review.

PMID:
19634707
11.

Osteopontin is upregulated in malignant and inflammatory pleural effusions.

Moschos C, Porfiridis I, Psallidas I, Kollintza A, Stathopoulos GT, Papiris SA, Roussos C, Kalomenidis I.

Respirology. 2009 Jul;14(5):716-22. doi: 10.1111/j.1440-1843.2009.01536.x. Epub 2009 May 19.

PMID:
19476604
12.

Pleural tuberculosis in patients with early HIV infection is associated with increased TNF-alpha expression and necrosis in granulomas.

Bezuidenhout J, Roberts T, Muller L, van Helden P, Walzl G.

PLoS One. 2009;4(1):e4228. doi: 10.1371/journal.pone.0004228. Epub 2009 Jan 19.

13.

Toll-like receptor-induced arginase 1 in macrophages thwarts effective immunity against intracellular pathogens.

El Kasmi KC, Qualls JE, Pesce JT, Smith AM, Thompson RW, Henao-Tamayo M, Basaraba RJ, K├Ânig T, Schleicher U, Koo MS, Kaplan G, Fitzgerald KA, Tuomanen EI, Orme IM, Kanneganti TD, Bogdan C, Wynn TA, Murray PJ.

Nat Immunol. 2008 Dec;9(12):1399-406. doi: 10.1038/ni.1671. Epub 2008 Nov 2.

14.

PDE4 inhibitors: current status.

Spina D.

Br J Pharmacol. 2008 Oct;155(3):308-15. doi: 10.1038/bjp.2008.307. Epub 2008 Jul 28. Review.

15.
16.

An open-label, single-arm pilot study in patients with severe plaque-type psoriasis treated with an oral anti-inflammatory agent, apremilast.

Gottlieb AB, Strober B, Krueger JG, Rohane P, Zeldis JB, Hu CC, Kipnis C.

Curr Med Res Opin. 2008 May;24(5):1529-38. doi: 10.1185/030079908X301866 . Epub 2008 Apr 16.

PMID:
18419879
17.
18.

Immune parameters as markers of tuberculosis extent of disease and early prediction of anti-tuberculosis chemotherapy response.

Djoba Siawaya JF, Bapela NB, Ronacher K, Veenstra H, Kidd M, Gie R, Beyers N, van Helden P, Walzl G.

J Infect. 2008 May;56(5):340-7. doi: 10.1016/j.jinf.2008.02.007. Epub 2008 Mar 21.

PMID:
18359089
19.

Molecular mechanisms linking wound inflammation and fibrosis: knockdown of osteopontin leads to rapid repair and reduced scarring.

Mori R, Shaw TJ, Martin P.

J Exp Med. 2008 Jan 21;205(1):43-51. doi: 10.1084/jem.20071412. Epub 2008 Jan 7.

20.

Metalloproteinases and their inhibitors: regulators of wound healing.

Gill SE, Parks WC.

Int J Biochem Cell Biol. 2008;40(6-7):1334-47. Epub 2007 Oct 26. Review.

Supplemental Content

Support Center